CLINICAL_TRIALS
trial_result
· 2018-09-26
Clinical Trial Update: Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis [Phase 2]
Summary
Phase 2 trial comparing dalbavancin to an active comparator in adult osteomyelitis; study terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Osteomyelitis | Phase 2 | Status: TERMINATED | Results posted: 2018-09-26